New migraine combo drug trial pulled before it started
Symptom relief
Terminated
This study aimed to test a new combination of naltrexone and acetaminophen for treating migraine attacks. It was designed for adults with migraine who would treat one attack per stage. The trial was withdrawn before enrolling any participants, so no results are available.
Phase: PHASE2 • Sponsor: Allodynic Therapeutics, Inc • Aim: Symptom relief
Last updated May 14, 2026 12:05 UTC